Professor Carl-Henrik Heldin joins Rarity Bioscience’s Scientific Advisory Board 

Rarity Bioscience is proud to announce that the esteemed Professor Carl-Henrik Heldin has joined its Scientific Advisory Board as an external scientific advisor. Professor Heldin’s extensive experience and research in molecular cell biology will greatly enhance Rarity Bioscience’s long-term vision and efforts to address unmet clinical needs with cutting-edge molecular techniques. 

I have had the privilege to follow the research and work by Professor Ulf Landegren at Uppsala University closely for many years and always been amazed by the intriguing molecular tools developed by his research group. I think the superRCA technology is especially interesting due to the direct and broad application within clinical cancer research, as well as potentially in cancer diagnosis and monitoring of cancer treatment."

Professor Carl-Henrik Heldin

Photo: Uppsala University

In addition to his research contributions, Professor Heldin has held significant leadership roles in the scientific community. He served as the Vice-President of the European Research Council and chaired the Nobel Foundation for a decade, from 2013 to 2023. His leadership and expertise have been widely recognized and respected globally. 

Professor Heldin’s addition to the Scientific Advisory Board marks a significant milestone in Rarity Bioscience’s mission to advance cancer research and improve patient outcomes. We look forward to the innovative advancements his expertise will bring to our research and development efforts! 

Article on Life Science Sweden

This news is also featured on Life Science Sweden’s website. Click on the button below to proceed to the article:

Share this article

Recommended articles